Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Canadian Journal of Anesthesia/Journal canadien d'anesthésie
Published in: Canadian Journal of Anesthesia/Journal canadien d'anesthésie 10/2016

01-10-2016 | Reports of Original Investigations

A multicentre randomized-controlled trial of inhaled milrinone in high-risk cardiac surgical patients

Authors: André Y. Denault, MD, PhD, Jean S. Bussières, MD, Ramiro Arellano, MD, Barry Finegan, MD, Paul Gavra, PhD, François Haddad, MD, Anne Q. N. Nguyen, PhD, France Varin, PhD, Annik Fortier, MSc, Sylvie Levesque, MSc, Yanfen Shi, MD, Mahsa Elmi-Sarabi, MSc, Jean-Claude Tardif, MD, Louis P. Perrault, MD, PhD, Jean Lambert, PhD

Published in: Canadian Journal of Anesthesia/Journal canadien d'anesthésie | Issue 10/2016

Login to get access

Abstract

Purpose

Inhaled milrinone (iMil) has been used for the treatment of pulmonary hypertension (PH) but its efficacy, safety, and prophylactic effects in facilitating separation from cardiopulmonary bypass (CPB) and preventing right ventricular (RV) dysfunction have not yet been evaluated in a clinical trial. The purpose of this study was to investigate if iMil administered before CPB would be superior to placebo in facilitating separation from CPB.

Methods

High-risk cardiac surgical patients with PH were randomized to receive iMil or placebo after the induction of anesthesia and before CPB. Hemodynamic parameters and RV function were evaluated by means of pulmonary artery catheterization and transesophageal echocardiography. The groups were compared for the primary outcome of the level of difficulty in weaning from CPB. Among the secondary outcomes examined were the reduction in the severity of PH, the incidence of RV failure, and mortality.

Results

Of the 124 patients randomized, the mean (standard deviation [SD]) EuroSCORE II was 8.0 (2.6), and the baseline mean (SD) systolic pulmonary artery pressure (SPAP) was 53 (9) mmHg. The use of iMil was associated with increases in cardiac output (P = 0.03) and a reduction in SPAP (P = 0.04) with no systemic hypotension. Nevertheless, there was no difference in the combined incidence of difficult or complex separation from CPB between the iMil and control groups (30% vs 28%, respectively; absolute difference, 2%; 95% confidence interval [CI], −14 to 18; P = 0.78). There was also no difference in RV failure between the iMil and control groups (15% vs 14%, respectively; difference, 1%; 95% CI, −13 to 12; P = 0.94). Mortality was increased in patients with RV failure vs those without (22% vs 2%, respectively; P < 0.001).

Conclusion

In high-risk cardiac surgery patients with PH, the prophylactic use of iMil was associated with favourable hemodynamic effects that did not translate into improvement of clinically relevant endpoints. This trial was registered at ClinicalTrials.gov; identifier: NCT00819377.

Literature
  1. Bernstein AD, Parsonnet V. Bedside estimation of risk as an aid for decision-making in cardiac surgery. Ann Thorac Surg 2000; 69: 823-8.View ArticlePubMed
  2. Solina A, Papp D, Ginsberg S, et al. A comparison of inhaled nitric oxide and milrinone for the treatment of pulmonary hypertension in adult cardiac surgery patients. J Cardiothorac Vasc Anesth 2000; 14: 12-7.View ArticlePubMed
  3. Feneck RO, Sherry KM, Withington PS, Oduro-Dominah A, European Multicenter Milrinone Trial Group. Comparison of the hemodynamic effects of milrinone with dobutamine in patients after cardiac surgery. J Cardiothorac Vasc Anesth 2001; 15: 306-15.View ArticlePubMed
  4. Couture P, Denault AY, Pellerin M, Tardif JC. Milrinone enhances systolic, but not diastolic function during coronary artery bypass grafting surgery. Can J Anesth 2007; 54: 509-22.View ArticlePubMed
  5. Jaski BE, Fifer MA, Wright RF, Braunwald E, Colucci WS. Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure. Dose-response relationships and comparison to nitroprusside. J Clin Invest 1985; 75: 643-9.View ArticlePubMedPubMed Central
  6. Cuffe MS, Califf RM, Adams KF Jr, et al. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. JAMA 2002; 287: 1541-7.View ArticlePubMed
  7. Majure DT, Greco T, Greco M, et al. Meta-analysis of randomized trials of effect of milrinone on mortality in cardiac surgery: an update. J Cardiothorac Vasc Anesth 2013; 27: 220-9.View ArticlePubMed
  8. Gelvez J, Fakioglu H, Olarte JL, Soliz A, Totapally BR, Torbati D. Effect of aerosolized milrinone during drug-induced pulmonary hypertension in lambs. Pharmacol Res 2004; 50: 87-91.View ArticlePubMed
  9. Lamarche Y, Malo O, Thorin E, et al. Inhaled but not intravenous milrinone prevents pulmonary endothelial dysfunction after cardiopulmonary bypass. J Thorac Cardiovasc Surg 2005; 130: 83-92.View ArticlePubMed
  10. Haraldsson A, Kieler-Jensen N, Ricksten SE. The additive pulmonary vasodilatory effects of inhaled prostacyclin and inhaled milrinone in postcardiac surgical patients with pulmonary hypertension. Anesth Analg 2001; 93: 1439-45.View Article
  11. Sablotzki A, Starzmann W, Scheubel R, Grond S, Czeslick EG. Selective pulmonary vasodilation with inhaled aerosolized milrinone in heart transplant candidates. Can J Anesth 2005; 52: 1076-82.View ArticlePubMed
  12. Lamarche Y, Perrault LP, Maltais S, Tetreault K, Lambert J, Denault AY. Preliminary experience with inhaled milrinone in cardiac surgery. Eur J Cardiothorac Surg 2007; 31: 1081-7.View ArticlePubMed
  13. Wang H, Gong M, Zhou B, Dai A. Comparison of inhaled and intravenous milrinone in patients with pulmonary hypertension undergoing mitral valve surgery. Adv Ther 2009; 26: 462-8.View ArticlePubMed
  14. Singh R, Choudhury M, Saxena A, Kapoor PM, Juneja R, Kiran U. Inhaled nitroglycerin versus inhaled milrinone in children with congenital heart disease suffering from pulmonary artery hypertension. J Cardiothorac Vasc Anesth 2010; 24: 797-801.View ArticlePubMed
  15. Carev M, Bulat C, Karanovic N, et al. Combined usage of inhaled and intravenous milrinone in pulmonary hypertension after heart valve surgery. Coll Antropol 2010; 34: 1113-7.PubMed
  16. Gong M, Lin XZ, Lu GT, Zheng LJ. Preoperative inhalation of milrinone attenuates inflammation in patients undergoing cardiac surgery with cardiopulmonary bypass. Med Princ Pract 2012; 21: 30-5.View ArticlePubMed
  17. Denault AY, Haddad F, Lamarche Y, et al. Pilot randomized controlled trial of inhaled milrinone in high-risk cardiac surgical patients. Surgery Curr Res 2014. DOI:10.​4172/​2161-1076.​1000192.
  18. Laflamme M, Perrault LP, Carrier M, Elmi-Sarabi M, Fortier A, Denault AY. Preliminary experience with combined inhaled milrinone and prostacyclin in cardiac surgical patients with pulmonary hypertension. J Cardiothorac Vasc Anesth 2015; 29: 38-45.View ArticlePubMed
  19. Haglund NA, Burdorf A, Jones T, et al. Inhaled milrinone after left ventricular assist device implantation. J Card Fail 2015; 21: 792-7.View ArticlePubMed
  20. Denault AY, Lamarche Y, Couture P, et al. Inhaled milrinone: a new alternative in cardiac surgery? Semin Cardiothorac Vasc Anesth 2006; 10: 346-60.View ArticlePubMed
  21. Buckley MS, Feldman JP. Nebulized milrinone use in a pulmonary hypertensive crisis. Pharmacotherapy 2007; 27: 1763-6.View ArticlePubMed
  22. Nguyen AQ, Theoret Y, Chen C, Denault A, Varin F. High performance liquid chromatography using UV detection for the quantification of milrinone in plasma: improved sensitivity for inhalation. J Chromatogr B Analyt Technol Biomed Life Sci 2009; 877: 657-60.View ArticlePubMed
  23. Hegazy N. Comparison of hemodynamic effects of inhaled milrinone and inhaled prostacyclin after adult cardiac surgery. J Appl Sci Res 2010; 6: 38-44.
  24. St-Pierre P, Deschamps A, Cartier R, Basmadjian AJ, Denault AY. Inhaled milrinone and epoprostenol in a patient with severe pulmonary hypertension, right ventricular failure, and reduced baseline brain saturation value from a left atrial myxoma. J Cardiothorac Vasc Anesth 2014; 28: 723-9.View ArticlePubMed
  25. Denault AY, Haddad F, Jacobsohn E, Deschamps A. Perioperative right ventricular dysfunction. Curr Opin Anesthesiol 2013; 26: 71-81.View Article
  26. Denault A, Lamarche Y, Rochon A, et al. Innovative approaches in the perioperative care of the cardiac surgical patient in the operating room and intensive care unit. Can J Cardiol 2014; 30: S459-77.View ArticlePubMed
  27. Bueltmann M, Kong X, Mertens M, et al. Inhaled milrinone attenuates experimental acute lung injury. Intensive Care Med 2009; 35: 171-8.View ArticlePubMed
  28. Merchant R, Chartrand D, Dain S, et al. Guidelines to the practice of anesthesia—revised edition 2015. Can J Anesth 2015; 62: 54-67.View ArticlePubMed
  29. Gavra P, Nguyen AQ, Beauregard N, Denault AY, Varin F. High-performance liquid chromatography assay using ultraviolet detection for urinary quantification of milrinone concentrations in cardiac surgery patients undergoing cardiopulmonary bypass. Biomed Chromatogr 2014; 28: 1084-9.View ArticlePubMed
  30. Gavra P, Nguyen AQ, Theoret Y, Litalien C, Denault AY, Varin F. A specific and sensitive HPLC-MS/MS micromethod for milrinone plasma levels determination after inhalation in cardiac patients. Ther Drug Monit 2014; 36: 663-8.View ArticlePubMed
  31. Beaulieu Y, Denault AY, Couture P, et al. Perioperative intravenous amiodarone does not reduce the burden of atrial fibrillation in patients undergoing cardiac valvular surgery. Anesthesiology 2010; 112: 128-37.View ArticlePubMed
  32. Denault AY, Couture P, Beaulieu Y, et al. Right Ventricular depression after cardiopulmonary bypass for valvular surgery. J Cardiothorac Vasc Anesth 2015; 29: 836-44.View ArticlePubMed
  33. Shi Y, Denault AY, Couture P, Butnaru A, Carrier M, Tardif JC. Biventricular diastolic filling patterns after coronary artery bypass graft surgery. J Thorac Cardiovasc Surg 2006; 131: 1080-6.View ArticlePubMed
  34. Rudski LG, Lai WW, Afilalo J, et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr 2010; 23: 685-713.View ArticlePubMed
  35. Denault AY, Tardif JC, Mazer CD, Lambert J, BART Investigators. Difficult and complex separation from cardiopulmonary bypass in high-risk cardiac surgical patients: a multicenter study. J Cardiothorac Vasc Anesth 2012; 26: 608-16.View ArticlePubMed
  36. Denault AY, Pearl RG, Michler RE, et al. Tezosentan and right ventricular failure in patients with pulmonary hypertension undergoing cardiac surgery: the TACTICS trial. J Cardiothorac Vasc Anesth 2013; 27: 1212-7.View ArticlePubMed
  37. Robitaille A, Denault AY, Couture P, et al. Importance of relative pulmonary hypertension in cardiac surgery: the mean systemic-to-pulmonary artery pressure ratio. J Cardiothorac Vasc Anesth 2006; 20: 331-9.View ArticlePubMed
  38. Haddad F, Guihaire J, Skhiri M, et al. Septal Curvature is marker of hemodynamic, anatomical, and electromechanical ventricular interdependence in patients with pulmonary arterial hypertension. Echocardiography 2014; 31: 699-707.View ArticlePubMed
  39. Schnittger I, Gordon EP, Fitzgerald PJ, Popp RL. Standardized intracardiac measurements of two-dimensional echocardiography. J Am Coll Cardiol 1983; 2: 934-8.View ArticlePubMed
  40. Hanton G, Gautier M, Bonnet P, Herbet A. Effect of milrinone on echocardiographic parameters after single dose in Beagle dogs and relationship with drug-induced cardiotoxicity. Toxicol Lett 2005; 155: 307-17.View ArticlePubMed
  41. Royse CF, Royse AG, Rohrlach R, Wright CE, Angus JA. The cardiovascular effects of adrenaline, dobutamine and milrinone in rabbits using pressure-volume loops and guinea pig isolated atrial tissue. Anaesth Intensive Care 2007; 35: 180-8.PubMed
  42. Carceles MD, Fuentes T, Aroca V, Lopez J, Hernandez J. Effects of milrinone on contractility and cyclic adenosine monophosphate production induced by beta1- and beta2-adrenergic receptor activation in human myocardium. Clin Ther 2007; 29: 1718-24.View ArticlePubMed
  43. Baim DS, McDowell AV, Cherniles J, et al. Evaluation of a new bipyridine inotropic agent—milrinone—in patients with severe congestive heart failure. N Engl J Med 1983; 309: 748-56.View ArticlePubMed
  44. Lobato EB, Florete O Jr, Bingham HL. A single dose of milrinone facilitates separation from cardiopulmonary bypass in patients with pre-existing left ventricular dysfunction. Br J Anaesth 1998; 81: 782-4.View ArticlePubMed
  45. Yamada T, Takeda J, Katori N, Tsuzaki K, Ochiai R. Hemodynamic effects of milrinone during weaning from cardiopulmonary bypass: comparison of patients with a low and high prebypass cardiac index. J Cardiothorac Vasc Anesth 2000; 14: 367-73.View ArticlePubMed
  46. Kim JH, Ham BM, Kim YL, et al. Prophylactic milrinone during OPCAB of posterior vessels: implication in angina patients taking beta-blockers. Eur J Cardiothorac Surg 2003; 24: 770-6.View ArticlePubMed
  47. Denault AY, Chaput M, Couture P, Hebert Y, Haddad F, Tardif JC. Dynamic right ventricular outflow tract obstruction in cardiac surgery. J Thorac Cardiovasc Surg 2006; 132: 43-9.View ArticlePubMed
  48. Packer M, Carver JR, Rodeheffer RJ, et al. Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. N Engl J Med 1991; 325: 1468-75.View ArticlePubMed
  49. Haddad F, Denault AY, Couture P, et al. Right ventricular myocardial performance index predicts perioperative mortality or circulatory failure in high-risk valvular surgery. J Am Soc Echocardiogr 2007; 20: 1065-72.View ArticlePubMed
  50. Woolfrey SG, Hegbrant J, Thysell H, et al. Dose regimen adjustment for milrinone in congestive heart failure patients with moderate and severe renal failure. J Pharm Pharmacol 1995; 47: 651-5.View ArticlePubMed
  51. Butterworth JF 4th, Hines RL, Royster RL, James RL. A pharmacokinetic and pharmacodynamic evaluation of milrinone in adults undergoing cardiac surgery. Anesth Analg 1995; 81: 783-92.PubMed
  52. Costachescu T, Denault A, Guimond JG, et al. The hemodynamically unstable patient in the intensive care unit: hemodynamic vs. transesophageal echocardiographic monitoring. Crit Care Med 2002; 30: 1214-23.View ArticlePubMed
  53. Dorman BH, Bond BR, Clair MJ, et al. Temporal synthesis and release of endothelin within the systemic and myocardial circulation during and after cardiopulmonary bypass: relation to postoperative recovery. J Cardiothorac Vasc Anesth 2000; 14: 540-5.View ArticlePubMed
  54. Bond BR, Dorman BH, Clair MJ, et al. Endothelin-1 during and after cardiopulmonary bypass: association to graft sensitivity and postoperative recovery. J Thorac Cardiovasc Surg 2001; 122: 358-64.View ArticlePubMed
  55. Kumar VH, Swartz DD, Rashid N, et al. Prostacyclin and milrinone by aerosolization improve pulmonary hemodynamics in newborn lambs with experimental pulmonary hypertension. J Appl Physiol 1985; 2010(109): 677-84.
Metadata
Title
A multicentre randomized-controlled trial of inhaled milrinone in high-risk cardiac surgical patients
Authors
André Y. Denault, MD, PhD
Jean S. Bussières, MD
Ramiro Arellano, MD
Barry Finegan, MD
Paul Gavra, PhD
François Haddad, MD
Anne Q. N. Nguyen, PhD
France Varin, PhD
Annik Fortier, MSc
Sylvie Levesque, MSc
Yanfen Shi, MD
Mahsa Elmi-Sarabi, MSc
Jean-Claude Tardif, MD
Louis P. Perrault, MD, PhD
Jean Lambert, PhD
Publication date
01-10-2016
Publisher
Springer US
Published in
Canadian Journal of Anesthesia/Journal canadien d'anesthésie / Issue 10/2016
Print ISSN: 0832-610X
Electronic ISSN: 1496-8975
DOI
https://doi.org/10.1007/s12630-016-0709-8

Other articles of this Issue 10/2016

Canadian Journal of Anesthesia/Journal canadien d'anesthésie 10/2016 Go to the issue

Reports of Original Investigations

Effects of anesthetics on early postoperative cognitive outcome and intraoperative cerebral oxygen balance in patients undergoing lung surgery: a randomized clinical trial

Reports of Original Investigations

Comparison of isoflurane and sevoflurane in cardiac surgery: a randomized non-inferiority comparative effectiveness trial

Editorials

Inhaled milrinone for pulmonary hypertension in high-risk cardiac surgery: silver bullet or just part of a broader management strategy?

In reply

In reply: Combined use of flexible bronchoscopy and video laryngoscopy for endotracheal intubation in patients with King laryngeal tube in situ

Images in Anesthesia

Bifid epiglottis in a patient with Pallister-Hall syndrome

Correspondence

“Winding down” guidelines for anesthesiologists: The Ottawa Hospital plan